Treatment with the stress agent prostaglandin A 2 (PGA 2 ) induces expression of the cyclin-dependent kinase inhibitor p21. Here, we present evidence that p21 expression increases through PGA 2 -triggered stabilization of the p21 mRNA and further show that these events require the mitogen-activated protein (MAP) kinase ERK. Binding experiments using either endogenous p21 mRNA or in vitro-labeled p21 transcripts revealed a specific PGA 2 -dependent association of the p21 mRNA with the RNA-binding protein HuR. Interestingly, although inhibition of the ERK pathway did not prevent the PGA 2 -triggered increase in cytoplasmic HuR, it did impair the formation of endogenous and in vitro [HuR-p21 mRNA] complexes and further prevented the PGA 2 -mediated stabilization of the p21 mRNA, suggesting that ERK-mediated events were required for binding HuR to the p21 mRNA and preventing its decay. RNA interference-based knockdown of HuR abundance further served to demonstrate the contribution of HuR-mediated p21 mRNA stabilization toward enhancing p21 expression after PGA 2 treatment. Collectively, our results indicate that PGA 2 stabilizes the p21 mRNA through an ERK-independent increase in cytoplasmic HuR levels and an ERK-dependent association of HuR with the p21 mRNA.
Stressful and proliferative stimuli activate complex signaling networks in mammalian cells. Among the ensuing gene regulatory processes, events influencing mRNA stability can effectively alter the profiles of expressed gene products (1, 2) . Messenger RNA turnover is controlled through the association of RNA-binding proteins that recognize specific RNA sequences and either increase or decrease transcript half-life (3, 4) . Best characterized among such RNA sequences are U-rich and AUrich elements, usually found in the 3Ј-untranslated region (UTR) 1 of short-lived mRNAs (5) such as those encoding many stress-regulated genes. For example, many proto-oncogenes (c-fos, c-myc), cytokines (interferons, interleukins), cell cycle regulatory proteins (cyclin A, cyclin B1, cdc25, cyclin-dependent kinase inhibitor p21), apoptosis-related proteins (bcl-2, cyclooxygenase-2), and growth factors (granulocyte-macrophage colony-stimulating factor, vascular endothelial growth factor) are all encoded by mRNAs whose half-lives are regulated under various stressful situations (5) (6) (7) (8) (9) (10) (11) . Similarly, many RNA-binding proteins have been described that selectively recognize and bind to AU-rich elements of labile mRNAs and regulate their post-transcriptional fate, including tristetraprolin, AUF1 (heterogeneous nuclear ribonucleoprotein D), KSRP, BRF1, and the Hu/elav (embryonic lethal abnormal vision) proteins (12) (13) (14) (15) (16) (17) (18) (19) .
A number of studies have documented the involvement of the Hu/elav protein HuR in regulating mRNA turnover and translation under situations of stress (12, 13, 20) . HuR is ubiquitously expressed, whereas the other Hu/elav proteins (HuB, HuC, and HuD) are primarily neuronal (21, 22) . HuR binds with great affinity and specificity to AU-rich elements in a variety of mRNAs, such as those mentioned above (12, 23) , and is believed to increase their stability, alter their translation, or mediate both events (13, 20, 24 -27 ). The precise mechanisms regulating HuR function remain to be fully elucidated, but it is becoming increasingly apparent that the subcellular localization of HuR is intimately linked to its function. HuR is predominantly (Ͼ90%) localized in the nucleus of unstimulated cells but can be exported to the cytoplasm through the action of CRM1 (and possibly additional factors) and is imported to the nucleus via transportins 1 and 2 (28 -30) .
Several stress-activated signaling pathways have been reported to modulate the cytoplasmic abundance of HuR or its binding ability. Activation of the MAP kinase-activated protein kinase 2, a downstream target of phosphorylation by MAP kinase p38, was found to enhance the cytoplasmic presence of HuR and increase the ability of HuR to bind to and stabilize target mRNAs encoding the urokinase-type plasminogen activator and its receptor (31) . Heat stress was shown to specifically enhance HuR-mediated export of hsp70 mRNA to the cytoplasm, purportedly through the association of HuR with the protein ligands pp32 and APRIL (32, 33) . Elevated activity of the AMP-activated protein kinase, an enzyme that participates in the cellular response to metabolic stresses, was found to reduce the cytoplasmic abundance of HuR. Conversely, reductions in AMP-activated protein kinase activity triggered by agents such as irradiation with short-wavelength ultraviolet light (UVC), increased the cytoplasmic abundance of HuR (34) and caused an HuR-dependent increase in the half-life of p21 mRNA (13) . Additional stress agents causing an elevation in cytoplasmic HuR levels include the alkylating agent methylmethane sulfonate, hydrogen peroxide, sodium arsenite and the cyclopentenone prostaglandin A 2 (PGA 2 ) (13) .
Treatment with the stress model agent PGA 2 causes growth inhibition associated with the apoptotic death of cultured cells and exhibits anti-tumor activity in vivo (2, (35) (36) (37) (38) (39) (40) (41) (42) (43) , although the mechanisms responsible for eliciting these effects are not well understood. Several microarray-based studies have led to the identification of mRNAs whose transcription and/or steadystate levels are regulated by PGA 2 and other cyclopentenone PGs (2, 44) . We and others have previously reported several gene expression changes occurring during the PGA 2 -triggered stress response, including the inhibition of cyclin D1 levels and the potent up-regulation of p21 expression (36, 45, (47) (48) (49) . Further analysis of the PGA 2 -mediated down-regulation of cyclin D1 expression revealed that PGA 2 decreased the stability of the cyclin D1 mRNA, identified a specific 390-base 3Ј-UTR segment involved in cyclin D1 mRNA decay, and suggested a role for AUF1 in these destabilization events (49) . Here, we expand on our earlier findings that PGA 2 treatment increased cytoplasmic HuR levels and heightened the association of HuR to the p21 3Ј-UTR (13) . Using the human non-small cell lung cancer line H1299, we provide a formal demonstration that p21 mRNA is stabilized upon treatment with PGA 2 . A variety of in vitro and in vivo binding assays provide further evidence that PGA 2 increases the association of p21 mRNA-HuR complexes, whereas interventions to reduce HuR indicate that the PGA 2 -stimulated p21 mRNA stabilization and increased p21 levels require HuR. Finally, our data show that the PGA 2 -triggered increase in the abundance of these complexes, the heightened stability of the p21 mRNA, and the elevated p21 production are all dependent on the activity of the MAP kinase ERK.
EXPERIMENTAL PROCEDURES
Cell Culture, Reagents, and Preparation of Cell Fractions-The human line H1299 (non-small cell lung carcinoma) was obtained from the American Type Culture Collection and maintained in RPMI 1640 medium supplemented with 10% fetal bovine serum and antibiotics. Cell counts were carried out using a hemacytometer. All experiments were performed using exponentially growing cells. Actinomycin D, staurosporine, and PGA 2 were from Sigma. Suramin, AG1478, herbimycin A, genistein, BAPTA-AM, PD98059, and SB202190 were from Calbiochem. U0126 was from Promega, and SP600125 was from Biomol Research Labs, Inc. Cytoplasmic and nuclear fractions were prepared as described previously (13) .
For the p21 promoter-reporter assays, transfections were carried out using standard calcium phosphate precipitation. Cells were transiently transfected with the plasmid pWWT-luc, a kind gift from Dr. B. Vogelstein (50) . The transfection of siRNAs (either control or targeting HuR) at a final concentration of 20 nM was carried out using OligofectAMINE (Invitrogen) according to the manufacturer's instructions; cells were collected for Western blotting or used for mRNA half-life determinations 48 h after transfection.
Nuclear Run-on-Assays were performed as described (51) with minor modifications. Briefly, 1 g of PCR-amplified, gel-purified DNA corresponding to each indicated gene was denatured and blotted onto nylon membranes. Nuclei from 2 ϫ 10 7 H1299 cells were isolated from each treatment group using lysis buffer (10 mM Tris (pH 7.5), 10 mM NaCl, 3 mM MgCl 2 , and 0.5% Nonidet P-40), and nascent RNAs were labeled by in vitro transcription using reaction buffer (100 mM KCl, 2.5 M MgCl 2 , 2.5 mM rATP, 2.5 mM rCTP, 2.5 mM rGTP, and 500 Ci [␣-32 P]UTP) for 30 min at 30°C; radiolabeled RNA was then isolated using the STAT-60 reagent. Membranes were blocked in 2 ml of hybridization buffer (10 mM Tris-HCl (pH 7.5), 4ϫ SSC, 1 mM EDTA, 0.1% SDS, 2ϫ Denhardt's Solution, 40% formamide, 100 g/ml yeast tRNA, 20 g/ml poly(A), and 2 g/ml human Cot-1 DNA) containing 100 g tRNA for 4 h, whereupon radiolabeled RNA (ϳ2 ϫ 10 6 cpm per hybridization bottle) was added and hybridized for 72 h at 55°C. Membranes were then washed extensively at 55°C with wash buffer (2ϫ SSC, 0.1% SDS, 15 min). Signals were visualized with a PhosphorImager (Amersham Biosciences).
Northern and Western Blot Analyses-Northern blot analysis was carried out using standard methodologies (36) . For the detection of the p21 mRNA, cyclin D1 mRNA, and 18 S rRNA oligomers 5Ј-CTGGGC-CGAAGAGGCGGCGGCAGGCCTTGCTGCCGCATGGGTTCTG-3Ј, 5Ј-GAGGTTGGCATCGGGGTACGCGCGGCGGATGGTTTCCACTTCGC-AGCACAGGAGCTGGTG-3Ј, and 5Ј-ACGGTATCTGATCGTCTTCGA-ACC-3Ј, respectively, were end-labeled using [␣- 32 P]dATP and terminal transferase. For the detection of cyclin A, cyclin B1, and gadd153, the corresponding PCR products were labeled using random primers. Northern blotting signals were quantitated with a PhosphorImager.
For mRNA half-life assessments, 3-4 independent experiments were performed. Actinomycin D (2 g/ml) was added, and total RNA was prepared at the times indicated (Figs. 2, 5, and 9 ). p21 mRNA half-lives were calculated after measuring p21 mRNA signals on Northern blots, normalizing them to 18 S rRNA signals, plotting the values as logarithmic scales, and calculating the time period required for the p21 mRNA to undergo a reduction to one-half of its initial abundance (before adding actinomycin D).
For Western blotting, whole-cell (15 g), cytoplasmic (20 g), or nuclear (5 g) lysates, prepared as described (13), were size-fractionated by SDS-PAGE and transferred onto polyvinylidene difluoride membranes. HuR was detected with a monoclonal antibody from Santa Cruz, p21 with a monoclonal antibody from Upstate Biotechnology, ␤-actin with a monoclonal antibody from Abcam, phosphorylated ERK (ERK1, ERK2) with a polyclonal antibody from Cell Signaling, and ␤-tubulin, histone deacetylase 2, and total ERK (ERK1, ERK2) with polyclonal antibodies from Santa Cruz. Following secondary antibody incubations, signals were detected by enhanced chemiluminescence.
Synthesis of Labeled Transcripts-Complementary DNA, prepared from total RNA extracted from H1299 cells, was used as the template for PCR amplification of different mRNA regions of p21. All 5Ј-oligonucleotides contained the T7 RNA polymerase promoter sequence 5Ј-CCAAGCTTCTAATACGACTCACTATAGGGAGA-3Ј (T 7 ) and, therefore, the resulting PCR fragments served as templates for the synthesis of corresponding RNAs. Transcription reactions were carried out in the presence of either [␣-
32 P]UTP (Amersham Biosciences) or biotinylated CTP (Sigma). Radiolabeled transcripts were used at a specific activity of 100,000 cpm/l (2-10 fmol/l) for RNA electrophoretic mobility shift assay (REMSA) analysis, whereas biotinylated transcripts were used for pull-down assays, as described (10) .
REMSA, REMSA Supershift, UV Cross-linking, and Biotin Pulldown Binding Assays-For analysis of the binding of endogenous proteins to radiolabeled transcripts, REMSA assays were carried out as described previously (13) . For REMSA supershift analysis, 4 g of antibody was incubated with lysates for 1 h on ice before the addition of radiolabeled RNA; all subsequent steps were as described for REMSA analysis. The IgG1 antibody used in the supershift assays was from BD Pharmingen. For cross-linking experiments, RNase T1-treated RNAprotein mixtures were exposed to UV light using a Stratalinker (Stratagene) and then electrophoresed through SDS-polyacrylamide gels. Gels were subsequently dried, and radioactivity was visualized using a PhosphorImager.
For biotin pull-down assays, 6 g of biotinylated transcripts was incubated with 120 g of cytoplasmic lysate for 30 min at 25°C. Complexes were isolated with paramagnetic streptavidin-conjugated Dynabeads (Dynal, Oslo, Norway), and pull-down material was analyzed by Western blotting.
Ca 2ϩ Measurement-H1299 cells were loaded with the Ca 2ϩ indicator fluo-4/AM (20 M for 30 min at room temperature; Molecular Probes) and incubated with PGA 2 (0 -60 M) diluted in Hepes-buffered solution containing 137 mM NaCl, 4.9 mM KCl, 1 mM CaCl 2 , 1.2 mM MgSO 4 , 1.2 mM NaH 2 PO 4 , 15 mM glucose, and 20 mM Hepes (pH 7.4). Confocal images were obtained every 2 min using a Zeiss LSM 510 microscope (Carl Zeiss) in the frame scan (xy) mode. Data are reported as F/F 0 , where F 0 refers to basal fluorescence intensity prior to PGA 2 treatment. Image processing and presentation were performed using IDL 5.5 software (Research Systems, Inc., Boulder, CO). All measurements were performed at room temperature (23-25°C) .
Immunoprecipitation (IP) Followed by Reverse Transcription (RT) and Real
Time PCR-For IP of endogenous RNA-protein complexes, whole-cell (1 mg) lysates were incubated (2 h, 4°C) with a 50% (v/v) suspension of Protein A-Sepharose beads (Sigma) that had been precoated with 30 g of either IgG1 (BD Pharmingen) or anti-HuR (Santa Cruz Biotechnology). Beads were washed using NT2 buffer (50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1 mM MgCl 2 , and 0.05% Nonidet P-40), incubated with 100 l of NT2 buffer containing 20 units of RNase-free DNase I for 15 min at 30°C, washed with NT2 buffer, and further incubated in 100 l of NT2 buffer containing 0.1% SDS and 0.5 mg/ml proteinase K (15 min at 55°C). RNA was extracted and precipitated in the presence of GlycoBlue (Ambion). The presence of p21 and GAPDH mRNAs in the IP materials was assessed by using the sequence-specific primer pairs 5Ј-GGGGAAGGGACACACAAGAAGA-3Ј and 5Ј-AAT-GAACTGGGGAGGGATGG-3Ј for the p21 PCR product and 5Ј-CAGGT-GGTCTCCTCTGACTTCAACA-3Ј and 5Ј-GGGTCTCTCTCTTCCTCTT-GTGCTCT-3Ј for the GAPDH PCR product.
RESULTS

Increased Expression of p21 in Response to PGA 2 Treatment
Occurs through Enhanced mRNA Stability-In keeping with earlier reports (49) , treatment of H1299 cells with PGA 2 caused a rapid and potent cessation of growth (Fig. 1A ) associated with changes in the expression of cell cycle-associated genes. Expression of cyclins A, B1, and D1 was reduced following PGA 2 treatment, whereas expression of the growth suppressors p21 (a cyclin-dependent kinase inhibitor) and gadd153 (a growthand DNA damage-inducible gene) was elevated, as detected by Northern blot analysis (Fig. 1B) . A direct assessment of transcription rates by a nuclear run-on assay revealed that the changes in steady-state levels of the mRNAs encoding p21 or cyclins A, B1, and D1 were unlikely to arise from altered gene transcription, because transcription rates were unaffected by PGA 2 treatment, as reported previously for cyclin D1 (49); the transcriptional up-regulation of gadd153 served as positive control ( Fig. 2A) .
The regulation of p21 expression was examined in greater detail. The transcriptional activity of the p21 promoter in H1299 cells, assessed using a luciferase-based reporter assay, did not change significantly following PGA 2 treatment (Fig.  2B) . Instead, assays were carried out to measure the half-life of the p21 mRNA by monitoring the rate of p21 mRNA clearance in H1299 cells where transcription was halted by actinomycin D treatment. These experiments revealed that PGA 2 treatment markedly increased the stability of the p21 mRNA from an apparent half-life of 4.2 h in untreated populations to one of 8 h in PGA 2 -treated cells (Fig. 2C ). These observations are consistent with the notion that PGA 2 treatment elevates p21 expression by increasing the stability of the p21 mRNA and prompted a further analysis of the mechanisms underlying these stabilization events.
RNA-binding Protein HuR Binds the 3Ј-UTR of the p21 mRNA-To investigate the process of p21 mRNA stabilization, we first sought to examine the association of p21 mRNA with the RNA-binding proteins potentially involved in regulating its stability. Three transcripts were synthesized for analysis in binding assays, i.e. one encompassing the coding region (CR) and 5Ј-UTR (Fig. 3A, line labeled CR) , one encompassing the full-length 3Ј-UTR (Fig. 3A, line labeled 3ЈFL) , and one encompassing the proximal region of the p21 3Ј-UTR where the AUrich element is located (Fig. 3A, 3ЈP) . The incubation of radiolabeled transcripts with cytoplasmic lysates (the subcellular A, three hours after the exposure of H1299 cells to 45 M PGA 2 , nuclei were isolated for nuclear run-on analysis to monitor transcription rates for the genes indicated (see "Experimental Procedures"). One microgram each of the PCR products corresponding to the genes shown were blotted onto nitrocellulose filters; pUC19 was plasmid DNA. ␤-Actin and GAPDH were included as control genes (not induced by PGA 2 ), GADD153 as a positive control gene (induced by PGA 2 ), and pUC19 as negative control (background binding to non-mammalian DNA). B, H1299 cells transfected with plasmid pWWT-luc (comprising the p21 promoter linked to the luciferase reporter gene) were either left untreated (c) or treated with PGA 2 for 16 h (PGA 2 ), whereupon lysates were prepared and used in luciferase assays. Experiments were performed three independent times, and data are shown as the means and the S.E. C, p21 mRNA stability was calculated in H1299 cells that were either left untreated or treated with 45 M PGA 2 for 12 h, whereupon 2 g/ml actinomycin D was added, RNA was prepared at the times indicated, p21 mRNA signals were measured by Northern blot analysis and normalized to 18S rRNA signals, and the resulting data were plotted on a logarithmic scale. Dashed horizontal lines, 50% of untreated. Data represent the mean Ϯ S.E. of four independent experiments. compartment where the stability of labile mRNAs is believed to be primarily regulated) followed by cross-linking of the resulting ribonucleoprotein complexes revealed a prominent PGA 2 -inducible band of ϳ36 -38 kDa (Fig. 3B) . No PGA 2 -inducible radiolabeled complexes were seen when using the CR transcript (Fig. 3B) or, in additional control binding assays, using nuclear lysates (not shown). Ribonucleoprotein complex formation investigated by REMSA analysis also revealed a PGA 2 -triggered increase in the binding of cytoplasmic proteins to the p21 full-length 3Ј-UTR (line labeled 3ЈFL in Fig. 3A ) and further showed that a region proximal to the CR (line labeled 3ЈP in Fig. 3A ) was sufficient to recapitulate the binding activity (Fig. 3C ), in keeping with earlier observations (13) .
Given that the RNA-binding protein HuR was shown previously to bind the p21 mRNA (13) , that its size matches that of the PGA 2 -inducible complex (ϳ36 kDa), and that its abundance in the cytoplasm was shown to increase in PGA 2 -treated colon cancer cells (13) , the following set of experiments were aimed at directly examining whether HuR associated with p21 transcripts in a PGA 2 -dependent manner in H1299 cells. Consistent with earlier observations (13), the cytoplasmic concentration of HuR was potently increased by PGA 2 treatment; as anticipated, no changes in either total or nuclear HuR were observed, a finding that is explained by the fact that HuR is Ͼ95% nuclear in resting H1299 cells, so the export of a small fraction of nuclear HuR to the cytoplasm causes marked elevations in the cytoplasmic HuR pool without eliciting perceptible changes in the nuclear HuR pool (13, 34) (Fig. 4A) . Cytoplasmic HuR bound a biotinylated transcript encompassing the 3Ј-UTR, as detected by Western blotting of the material pulled down using streptavidin-coated beads; such assays failed to pull down HuR when using a biotinylated CR transcript (Fig.  4B) . Supershift REMSA assays using cytoplasmic lysates from PGA 2 -treated cells revealed a prominent band exhibiting slower migration when complexes were incubated with an antiHuR antibody (Ab), but not with a control IgG1 Ab. Together, these findings indicate that HuR abundance increases in the cytoplasm of H1299 cells following PGA 2 treatment and that endogenous HuR is capable of binding the 3Ј-UTR of p21 in vitro.
Requirement of the ERK Pathway in the PGA 2 -mediated p21 Induction-PGA 2 was previously shown to induce several MAP kinase pathways (42) . Therefore, we sought to examine whether MAP kinase-regulated events contributed to the PGA 2 -mediated induction of p21 expression. To this end, we studied the influence of specific inhibitors of the MAP kinases ERK, JNK, and p38 on the time-dependent increase in p21 expression by PGA 2 treatment (Fig. 5A) . As shown in the PGA 2 treatment groups depicted in Fig. 5A , pre-treatment with either SP600125 (a JNK inhibitor) or SB202190 (a p38 inhibitor) failed to block the PGA 2 -mediated induction in p21 mRNA levels seen in the absence of pre-treatment with inhibitors (treatment group marked with a dash in Fig. 5A ). By contrast, pre-treatment with the ERK inhibitor U0126 potently abro- FIG. 3 . Increased binding to the p21 3-UTR in response to PGA 2 . A, schematic representation of the p21 mRNA, depicting the coding region (black) and the AU-rich region (gray). Transcripts spanning the 5Ј-UTR and coding region (CR) and either the full-length 3Ј-UTR (3ЈFL) or the proximal 3Ј-UTR (3ЈP) are shown. B, detection of p21 mRNA-bound proteins by electrophoresis in SDS-containing polyacrylamide gels. Transcripts of 3ЈFL and CR were radiolabeled in vitro and then incubated with lysates from H1299 cells that were either left untreated (c) or treated with PGA 2 for 6 h (PG); f, control lanes depicting transcripts processed similarly but without incubation with protein lysate. Following cross-linking and digestion with RNases, samples were denatured and size-fractionated by SDS-PAGE. Signals were visualized on dried gels using a PhosphorImager. MWM, molecular weight marker. C, samples were prepared as indicated in panel B using 3ЈP and 3ЈFL, but size-fractionation was carried out by REMSA analysis using native gels.
FIG. 4. Increased cytoplasmic localization of HuR and elevated binding to p21 transcripts following PGA2 treatment. A,
representative Western blot analysis of HuR abundance in either whole-cell (Total; 10 g), cytoplasmic (Cytopl.; 20 g) or nuclear (Nuclear; 5 g) lysates. Blots were stripped and reprobed to detect nucleusspecific histone deacetylase 1 and cytoplasm-specific ␤-tubulin. B, the biotinylated transcripts CR or 3ЈP were incubated with 40 g of cytoplasmic lysate, and the resulting ribonucleoprotein complexes were pulled down using streptavidin-coated beads. HuR was detected by Western blot analysis of the pull-down material. C, REMSA supershift. Samples were prepared from PGA 2 -treated cells as described in the legend of Fig. 3C and subsequently incubated with either control IgG1 (IgG1 Ab) or anti-HuR (HuR Ab) antibodies before electrophoresis through native gels. gated this induction, revealing the involvement of the ERK pathway in the up-regulation of p21 expression by PGA 2 (Fig.  5A) . Treatment with each of the MAP kinase inhibitors alone (treatment groups marked c in Fig. 5A ) was without effect.
The inhibitory effect of U0126 was not elicited through diminished transcription rates, because nuclear run-on assays (performed as described in Fig. 2B ) revealed that U0126 did not significantly decrease the transcription rate of the p21 gene (Fig. 5B, bar labeled U) . Moreover, mRNA half-life measurements revealed that U0126 reduced the stability of the p21 mRNA in both untreated and PGA 2 -treated populations, as measured by actinomycin D-based assays (Fig. 5C ). The timedependent induction of p21 expression in PGA 2 cells, detected by Western blotting (Fig. 6A, PGA 2 lanes) , was also potently suppressed under conditions of ERK inhibition (Fig. 6A,  UϩPGA 2 lanes) . ERK activity in this inhibitory paradigm was assessed by monitoring the levels of ERK phosphorylation; as shown, phospho-ERK signals were markedly elevated after the addition of the prostaglandin (Fig. 6B, PGA 2 lanes) but was strongly suppressed in cells pre-treated with U0126 (Fig. 6B,  UϩPGA 2 lanes) . To further elucidate the PGA 2 -triggered signaling events leading to ERK phosphorylation, the effect of inhibitors blocking events upstream of ERK phosphorylation was tested (Fig. 6C) . Inhibitors of growth factor receptors (such as the broad-spectrum inhibitor suramin or the EGFP-specific inhibitor AG1478) did not prevent the PGA 2 -stimulated phosphorylation of ERK. Similarly, inhibition of tyrosine phosphorylation appeared to have either no effect (genistein) or a modest effect (herbimycin A) on ERK phosphorylation. By contrast, inhibition of MEK activity using either U0126 or PD98059 effectively suppressed the PGA 2 -mediated phosphorylation of ERK. In keeping with the notion that PGA 2 causes a rapid and robust mobilization of Ca 2ϩ (52) , use of the intracellular calcium chelator BAPTA-AM potently inhibited ERK phosphorylation in PGA 2 -treated cells. This finding prompted a further testing of the possibility that protein kinase C might also function upstream of ERK in PGA 2 -triggered events. Indeed, use of the protein kinase C inhibitor staurosporine also prevented ERK phosphorylation in PGA 2 -treated cells (Fig. 6C) . In H1299 cells, intracellular [Ca 2ϩ ] increased dramatically following treatment with PGA 2 , as assessed by confocal microscopy using fluo-4 as a Ca 2ϩ indicator (Fig. 7A ). The effect of PGA 2 on the elevation of intracellular Ca 2ϩ levels was time-and dosedependent (Fig. 7, panels B and C) ; the EC 50 of PGA 2 was found to be ϳ10 M. Together, these observations indicate that PGA 2 -triggered activation of the ERK pathway is likely initiated by Ca 2ϩ -dependent events and further show that the ERK-regulated induction of p21 expression after PGA 2 treatment does not involve changes in p21 gene transcription.
The PGA 2 -triggered Association of HuR with p21 mRNA Requires ERK Activity-Analysis of the endogenous association between HuR and p21 mRNA was carried out by IP assays followed by RT-PCR-based detection of the p21 mRNA in the IP material (23, 53) . As shown, Ca 2ϩ -regulated events influenced the increased association between HuR and target p21 mRNA, because the p21 mRNA was strongly enriched in HuR IP samples prepared from PGA 2 -treated cells but not in HuR IP samples from cells that were pre-treated with either BAPTA-AM (Fig. 8A, lanes labeled B) or staurosporine (Fig. 8A , lanes labeled St) before stimulation with PGA 2 . Similarly, ERK activity was necessary for the increased association between HuR and target p21 mRNA, because pre-treatment with U0126 (Fig.  8B , lanes labeled U) also reversed the increased association of the p21 mRNA with HuR in PGA 2 -treated cells (Fig. 8B, top) . In these assays, the specificity of the [HuR-p21 mRNA] interaction was revealed by the distinctly lower detection of p21 mRNA in IPs using a control IgG1 antibody; as shown in the IgG1 lanes, amplification of the p21 product by RT-PCR was markedly reduced (Fig. 8) . Further controls included detection of the abundant housekeeping GAPDH mRNA, which is not a target of HuR and was found as a low-grade contaminating transcript in all IPs. The routine assessment of GAPDH mRNA further ensured that equal amounts of cellular lysate were used in all IP reactions (Fig. 8) .
Unexpectedly, however, ERK activity did not seem to be required for increasing the cytoplasmic abundance of HuR (Fig.  8B, bottom) , because treatment with U0126 did not prevent the elevation of HuR levels in the cytoplasm. This observation supports the notion that the association of HuR with target transcripts is subject to further ERK-modulated regulation that is independent of the cytoplasmic export of HuR. 
Suppression of HuR Expression by RNA Interference Prevents
the PGA 2 -mediated Stabilization of p21 mRNA and Induction of p21-Finally, to ascertain if HuR directly contributed to the induction of p21 expression levels in PGA 2 -treated cells, an RNA interference-based approach was devised. H1299 cells were transfected with either a control siRNA or an siRNA targeting HuR (see "Experimental procedures"). As shown, the use of HuR siRNA molecules reduced HuR expression to ϳ20 -25% of the levels seen in the control transfection group (Fig.  9A) . Importantly, this reduction in HuR abundance markedly lowered p21 levels, both basal and PGA 2 -induced. These alterations in p21 expression were mediated, at least in part, by changes in p21 mRNA levels in the different siRNA transfection groups (Fig. 9B) ; of note, the siRNA transfection procedures alone elevated p21 mRNA levels, because transfected cells exhibited elevated p21 mRNA levels as compared with those in the untransfected populations (Fig. 9B, lanes marked  with a dash) . Moreover, the changes in steady-state levels of the p21 mRNA were likely influenced by differences in the stability of the p21 mRNA, as measured using actinomycin D-based approaches (Fig. 9C) . As shown, in the control siRNA transfection group (labeled Ctrl. in Fig. 9B ), the p21 mRNA apparent half-life increased from 6.7 to 11.5 h after PGA 2 treatment; by contrast, in the HuR siRNA transfection group the p21 mRNA half-life remained essentially unchanged (6 and 6.5 h in the control and PGA 2 -treated populations, respectively). Taken together, our findings indicate that activation of the ERK pathway, likely triggered through increased intracellular Ca 2ϩ , contributes to the enhancement of p21 mRNA stability and the increase of p21 expression following treatment with the cyclopentenone PGA 2 and implicates HuR in eliciting these effects.
DISCUSSION
In this investigation, we have obtained evidence supporting the involvement of the ERK pathway in the stabilization and induced expression of the p21 mRNA after PGA 2 treatment. Our results further show that exposure to PGA 2 increases the cytoplasmic abundance of the RNA-binding protein HuR and enhances the formation of [HuR-p21 mRNA] complexes. The involvement of HuR in the PGA 2 -mediated stabilization of the p21 mRNA was demonstrated through RNAi-based interventions to reduce HuR abundance, which lowered the half-life of the p21 mRNA and strongly diminished p21 expression.
PGA 2 -triggered Signaling Events-The signal transduction pathways activated by exposure to PGA 2 remain largely unknown. Whereas conventional prostaglandins such as PGE 2 and PGD 2 trigger cellular responses by acting on cell surface receptors (54), the cyclopentenone prostaglandins PGJ 2 , PGA 1 , and PGA 2 are actively transported into cells and have been reported to localize in the endoplasmic reticulum and in the nucleus (55) (56) (57) . In the nucleus, high-affinity binding of PGJ 2 to the transcription factor peroxisome proliferation-activated receptor-␥ (PPAR␥) and PPAR␣ leads to the activation of PPAR-regulated gene expression, whereas binding to the transcription factors AP-1 and NF-B represses gene transcription (58 -61) . PGA 1 and PGA 2 have also been shown to target PPAR, but only at very high concentrations of ligand (62, 63) . Moreover, the majority of changes in stress response-and cell cycle-associated gene expression elicited by cyclopentenones do not appear to be regulated by their effects on PPAR (reviewed in 57). The ␣,␤-unsaturated carbonyl group of these PGs contains an electrophilic center that is capable of reacting with nucleophiles such as the sulfhydryl group of cysteines present in reduced glutathione or cellular proteins (57, 64, 65) . It is thus very likely that cyclopentenones cause protein damage, either by direct alkylation of cysteine residues present in many proteins or by impairing the cellular machinery that maintains protein structural integrity (57) . Cyclopentenones have also been shown to induce the unfolded protein response, a coordinated set of events triggered when damaged or misfolded proteins accumulate in the endoplasmic reticulum.
In addition to events triggered through mechanisms involving the alkylation of cysteine residues on nascent proteins or other indirect mediators, treatment with PGA 2 causes a rapid increase in intracellular [Ca 2ϩ ] i (Fig. 7) (Fig. 6C) . In this regard, the discovery that the inhibition of protein kinase C by staurosporine also prevented the PGA 2 -triggered activation of ERK further suggests that the Ca 2ϩ -mediated events leading to ERK activation by PGA 2 may be elicited through protein kinase C. Additional analysis of possible upstream mediators of ERK activation by PGA 2 suggested that neither growth factor receptors nor tyrosine kinases were prominently involved in these effects but did support the participation of the ERK upstream kinase MEK (Fig. 6C) .
ERK-regulated [HuR-p21 mRNA] Binding That Is Independent of Cytoplasmic HuR Export-A significant body of literature has previously shown that HuR binding to target mRNAs as well as HuR-mediated transcript stabilization and translation correlated closely with the cytoplasmic levels of HuR. The present data showing that pre-treatment with the ERK inhibitor U0126 prevented the PGA 2 -stimulated binding of HuR to the p21 mRNA but did not affect the PGA 2 -triggered increase of HuR presence in the cytoplasm (Fig. 8B) support the notion that the association of HuR with target transcripts is subject to further ERK-modulated regulation that is independent of the cytoplasmic presence of HuR. It will be of great interest to investigate if the inhibition of binding occurs in the nucleus, where we recently found HuR to bind both the p21 mRNA and the p21 pre-mRNA (67) . Furthermore, it will be important to determine whether treatments with BAPTA-AM, staurosporine, or U0126 promote the nuclear dissociation of [HuR-p21 mRNA] complexes or instead prevent their formation. Alternatively, it is possible that the reduced binding take place through cytoplasmic events. Given the current notion that HuR participates in the export of target mRNAs and the lack of evidence supporting the binding of HuR to target mRNAs de novo in the cytoplasm, inhibitory interventions affecting MEK function or Ca 2ϩ -triggered events may be predicted to operate by dissociating (instead of preventing the formation of) [HuRp21 mRNA] complexes.
ERK-regulated p21 mRNA Stability-The transcript stability data further suggest that ERK activity may be important for regulating p21 mRNA half-life both in unstimulated cells and in PGA 2 -stimulated cells. In unstimulated populations, incubation with U0126 caused a reduction in p21 mRNA stability from 4.2 to 2 h, whereas in the PGA 2 -treated groups pre-incubation with U0126 reduced p21 mRNA stability from 8 to 5 h (Fig. 5C ). How the ERK pathway regulates p21 mRNA stability in each group remains to be directly investigated, but it is likely to involve the altered association of p21 mRNA with additional RNA-binding proteins. In this regard, RNA-binding protein AUF1, which promotes transcript destabilization, has also been shown to associate with p21 mRNA (67) . Interestingly, the phosphorylation status of p40 AUF1 was shown to affect the binding and half-life of AUF1 target mRNAs, although the potential involvement of the ERK pathway in these phosphorylation events remains to be established (68) . Tristetraprolin, another decay-promoting RNA-binding protein, was recently shown to function in an ERK-dependent manner toward regulating the stability of its own mRNA (46) and may likewise influence p21 mRNA stability. A systematic characterization of all of the proteins that bind a biotinylated p21 transcript in pull-down assays is underway. It will be interesting to examine which of the identified RNA-binding proteins exhibit ERK-dependent regulation of target mRNA turnover. Finally, it will also be important to study if other stresses such as UVC irradiation also require ERK activation to elicit the HuR-regulated mRNA stabilization and translation (13, 20) .
Proposed Mechanism Whereby PGA 2 Regulates p21 mRNA Stabilization-Taking into consideration all of the data described here, the stress model agent PGA 2 appears to trigger two types of effects leading to the stabilization of the p21 mRNA. First, PGA 2 treatment causes an increase in cytoplasmic HuR levels associated with the increased abundance of [HuR-p21 mRNA] complexes. According to our observations, HuR is necessary for the stabilization and increased expression of the p21 mRNA in PGA 2 -treated cells (Fig. 9) . Second, PGA 2 mediated activation of ERK is required to achieve p21 mRNA stabilization. Our data are consistent with the notion that the presence of HuR in the cytoplasm is necessary but not sufficient for the stabilization of the p21 mRNA, because the inhibition of ERK activity does not block the cytoplasmic increase of HuR but does prevent HuR binding to the p21 mRNA and lowers the p21 mRNA stability and p21 expression (Figs. 5-7) . Experiments are in progress to identify the factor(s) through which ERK mediates these effects, which likely involve the interplay of decay-and stability-promoting RNA-binding proteins acting upon the p21 mRNA, as was recently described for a different stress agent (67) . It will also be interesting to investigate whether the post-transcriptional regulation of other HuR target mRNAs is controlled by PGA 2 treatment in a similar fashion.
The findings reported in this investigation illustrate the multiplicity of levels at which gene expression is regulated post-transcriptionally. In turn, the control of mRNA binding, subcellular mRNA distribution, and mRNA stabilization for translation into functional gene product all contribute to ensuring that mammalian cells respond adequately to changes in the environment.
